Microfluidics Technology in SARS-CoV-2 Diagnosis and Beyond: A Systematic Review

Abstract

With the progression of the COVID-19 pandemic, new technologies are being implemented for more rapid, scalable, and sensitive diagnostics. The implementation of microfluidic techniques and their amalgamation with different detection techniques has led to innovative diagnostics kits to detect SARS-CoV-2 antibodies, antigens, and nucleic acids. In this review, we explore the different microfluidic-based diagnostics kits and how their amalgamation with the various detection techniques has spearheaded their availability throughout the world. Three other online databases, PubMed, ScienceDirect, and Google Scholar, were referred for articles. One thousand one hundred sixty-four articles were determined with the search algorithm of microfluidics followed by diagnostics and SARS-CoV-2. We found that most of the materials used to produce microfluidics devices were the polymer materials such as PDMS, PMMA, and others. Centrifugal force is the most commonly used fluid manipulation technique, followed by electrochemical pumping, capillary action, and isotachophoresis. The implementation of the detection technique varied. In the case of antibody detection, spectrometer-based detection was most common, followed by fluorescence-based as well as colorimetry-based. In contrast, antigen detection implemented electrochemical-based detection followed by fluorescence-based detection, and spectrometer-based detection were most common. Finally, nucleic acid detection exclusively implements fluorescence-based detection with a few colorimetry-based detections. It has been further observed that the sensitivity and specificity of most devices varied with implementing the detection-based technique alongside the fluid manipulation technique. Most microfluidics devices are simple and incorporate the detection-based system within the device. This simplifies the deployment of such devices in a wide range of environments. They can play a significant role in increasing the rate of infection detection and facilitating better health services.

Breast Cancer Management in the Era of Covid-19; Key Issues, Contemporary Strategies, and Future Implications

“…As mentioned, at the start of the pandemic, there were no known effective treatments or vaccines for COVID-19 and primarily relied on early diagnosis. 120 , 121 This impacted the diagnosis and management of breast cancer patients during the pandemic. This included concerns with late diagnosis due to lockdown and other measures, and the subsequent impact on potential neoadjuvant treatment regimes, including NET, as a result of delays in surgery.…”

Microfluidic space coding for multiplexed nucleic acid detection via CRISPR-Cas12a and recombinase polymerase amplification

“…Microfluidics technology has been extensively used for molecular detection 39 – 42 . However, common microfluidic platforms have complicated fluidic networks, and often require valves, accessory pumps or other complex controlling systems 43 , 44 . Thus, they are not ideal for the quick and on-site detection of multiple targets 45 .…”

COVID-19 surveillance in wastewater: An epidemiological tool for the monitoring of SARS-CoV-2

“…The available microfluidic kits offer a rapid, cost-effective, and precise detection overall; therefore, they are appropriate in settings where resources are scarce for point-of-care testing (POCT). Integrated microfluidic devices have applications in whole-genome sequencing, COVID-19 progression, and intratracheal neutralization of a virus (Jamiruddin et al, 2022).…”